RARA and leukemia: Unique mutations that cause amino acid substitutions, such as RasV12, and the production of fusion proteins, for example PML-RARα generated via T(15;17)(q22;12) translocation, have been identified as candidates for gene aberration responsible for the diseases in several types of human leukemia and lymphoma cells [47,48,49].